Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4380221 | 0.95 | CYP3A4 (0.50) | CYP3A4TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL11213966 | 0.93 | TSHR (0.52) | CYP3A4TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL25170072 | 0.86 | CYP3A4 (0.43) | CYP3A4TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL1009658 | 0.86 | CYP3A4 (0.43) | CYP3A4TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL5850293 | 0.86 | CYP3A4 (0.43) | CYP3A4TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL29245227 | 0.86 | CYP3A4 (0.43) | CYP3A4TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL178129 | 0.85 | CYP3A4 (0.73) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| Ammonia Solution, Strong SCHEMBL28664397 | 0.84 | CYP3A4 (0.41) | CYP3A4TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL178107 | 0.83 | CYP3A4 (0.62) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL104844 | 0.83 | CYP3A4 (0.68) | CYP3A4TSHRALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350511-A | Uranium thorium specific capture agent in complex solution system, synthesis method and application thereof | 浙江创欣新材料有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119350511-A | Uranium thorium specific capture agent in complex solution system, synthesis method and application thereof | 浙江创欣新材料有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-117024658-A | Phospholipid terminal functionalized rare earth isoprene rubber and preparation method and application thereof | 海南天然橡胶产业集团股份有限公司 | 2023-11-10 | — | — | CN | disclosed |
| EP-3222624-B1 | IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME | CENTRAL GLASS CO LTD (JP) | 2019-11-06 | — | — | EP | disclosed |
| US-10287165-B2 | Imidic acid compound having divalent anion and process for producing the same | CENTRAL GLASS CO., LTD. (JP) | 2019-05-14 | — | — | US | disclosed |
| EP-2389348-B1 | PROCESS FOR THE SYNTHESIS OF BETA GLYCEROL PHOSPHATE | SIGMA ALDRICH CO LLC (US) | 2017-11-15 | — | — | EP | disclosed |
| EP-3222624-A1 | IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME | Central Glass Co., Ltd. (JP) | 2017-09-27 | — | — | EP | disclosed |
| US-20170267528-A1 | IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME | CENTRAL GLASS CO., LTD. (JP) | 2017-09-21 | — | — | US | disclosed |
| US-8420848-B2 | Process for the synthesis of beta glycerol phosphate | SIGMA-ALDRICH CO. LLC (US) | 2013-04-16 | — | — | US | disclosed |
| US-20120041222-A1 | PROCESS THE SYNTHESIS OF BETA GLYCEROL PHOSPHATE | SIGMA-ALDRICH CO. (US) | 2012-02-16 | — | — | US | disclosed |
| US-5399577-A | Lipoxygenase and cyclooxygenase inhibitor, antiasthma, antiinflammatory | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1995-03-21 | — | — | US | disclosed |
| EP-0633254-A1 | NOVEL ISOXAZOLE DERIVATIVE AND SALT THEREOF | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1995-01-11 | — | — | EP | disclosed |
| EP-0376745-B1 | Optical recording medium and process for the production thereof | TOYO INK MFG CO (JP) | 1994-12-07 | — | — | EP | disclosed |
| EP-0623603-A1 | STYRENE DERIVATIVE AND SALTS THEREOF | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1994-11-09 | — | — | EP | disclosed |
| US-5182284-A | Antiasthmatic agent, antiallergen, antiinflammatory agent | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1993-01-26 | — | — | US | disclosed |
| EP-0465659-A1 | PIPERAZINE COMPOUND, PRODUCTION THEREOF, AND MEDICINAL USE THEREOF | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 1992-01-15 | — | — | EP | disclosed |
| US-4943681-A | PHTHALOCYANINE COMPLEX, HIGH SENSITIVITY, LASERS | TOYO INK MANUFACTURING CO., LTD. (JP) | 1990-07-24 | — | — | US | disclosed |
| EP-0376745-A2 | Optical recording medium and process for the production thereof | TOYO INK MANUFACTURING CO., LTD. (JP) | 1990-07-04 | — | — | EP | disclosed |
| US-4851399-A | Isoquinoline derivatives and their use as anti-cancer agents | GLAXO GROUP LIMITED (GB) | 1989-07-25 | — | — | US | disclosed |
| US-4309422-A | INSECTICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1982-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170267528-A1 | IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME | CA2, CA6, CHRM1 | CYP3A4 415/4885TSHR 929/4885ALDH1A1 975/4885 |
| US-10287165-B2 | Imidic acid compound having divalent anion and process for producing the same | CA2, CA6, CHRM1 | CYP3A4 415/4885TSHR 929/4885ALDH1A1 975/4885 |
| US-20120041222-A1 | PROCESS THE SYNTHESIS OF BETA GLYCEROL PHOSPHATE | GK, GNPAT, AGPAT5 | CYP3A4 1991/4885TSHR 4346/4885ALDH1A1 2072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.